Ownership history in ORBIMED ADVISORS LLC · 9 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in C4 THERAPEUTICS INC (CCCC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,404,902 | -3,830,244 | -73.2% | 0.05% | $2.7M | $1.91 |
| 2025 Q3 | REDUCED | 5,235,146 | -1,595,154 | -23.4% | 0.27% | $11.6M | $2.22 |
| 2025 Q2 | UNCHANGED | 6,830,300 | — | 0% | 0.24% | $9.8M | $1.43 |
| 2025 Q1 | ADDED | 6,830,300 | +6,680,300 | +4453.5% | 0.26% | $10.9M | $1.60 |
| 2024 Q4 | REDUCED | 150,000 | -4,227,900 | -96.6% | 0.01% | $540K | $3.60 |
| 2024 Q4 | UNCHANGED | 4,377,900 | — | 0% | 0.32% | $15.8M | $3.60 |
| 2024 Q3 | ADDED | 4,377,900 | +4,227,900 | +2818.6% | 0.45% | $25.0M | $5.70 |
| 2024 Q3 | REDUCED | 150,000 | -1,363,058 | -90.1% | 0.02% | $855K | $5.70 |
| 2024 Q2 | INITIATED | 1,513,058 | — | — | 0.14% | $7.0M | — |
As of 2025 Q4 — sorted by position size